Impact of GAN artifacts for simulating mammograms on identifying mammographically occult cancer.

Purpose: Generative adversarial networks (GANs) can synthesize various feasible-looking images. We showed that a GAN, specifically a conditional GAN (CGAN), can simulate breast mammograms with normal, healthy appearances and can help detect mammographically-occult (MO) cancer. However, similar to other GANs, CGANs can suffer from various artifacts, e.g., checkerboard artifacts, that may impact the quality of the final synthesized image, as well as the performance of detecting MO cancer. We explored the types of GAN artifacts that exist in mammogram simulations and their effect on MO cancer detection.

Approach: We first trained a CGAN using digital mammograms (FFDMs) of 1366 women with normal/healthy breasts. Then, we tested the trained CGAN on an independent MO cancer dataset with 333 women with dense breasts (97 MO cancers). We trained a convolutional neural network (CNN) on the MO cancer dataset, in which real and simulated mammograms were fused, to identify women with MO cancer. Then, a radiologist who was independent of the development of the CGAN algorithms evaluated the entire MO cancer dataset to identify and annotate artifacts in the simulated mammograms.

Results: We found four artifact types, including checkerboard, breast boundary, nipple-areola complex, and black spots around calcification artifacts, with an overall incidence rate over 69% (the individual incident rate ranged from 9% to 53%) from both normal and MO cancer samples. We then evaluated their potential impact on MO cancer detection. Even though various artifacts existed in the simulated mammogram, we found that it still provided complementary information for MO cancer detection when it was combined with the real mammograms.

Conclusions: We found that artifacts were pervasive in the CGAN-simulated mammograms. However, they did not negatively affect our MO cancer detection algorithm; the simulated mammograms still provided complementary information for MO cancer detection when combined with real mammograms.